The company is aggressively expanding its oncology pipeline with ongoing Phase 3 trials for sigvotatug vedotin in lung cancer and planned studies in other cancers. A Phase 3 readout for multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback